NCT01948180 — Lymphoma, Extranodal NK-T-Cell trial site landscape

Public-registry site landscape for NCT01948180, a Lymphoma, Extranodal NK-T-Cell study sponsored by Cell Medica Ltd. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT01948180 (registry record)
Sponsor	Cell Medica Ltd
Condition(s)	Lymphoma, Extranodal NK-T-Cell; EBV
Phase	PHASE2
Listed sites	11
Site countries	United States, France, South Korea, United Kingdom

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT01948180 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.